# Product B continuation handoff

## 1. Executive status

**PRODUCT B FUNCTIONALLY HEALTHY — FORMAL ACCEPTANCE EVIDENCE INCOMPLETE**

Product B implementation, production deployment, database rollout, regression testing, and read-only production review are complete. The unfinished work is formal acceptance evidence; it is not Product B development, migration work, or a reproduced product defect.

## 2. Release identity

- Repository: `IvayloNanev/Pulse-Studio`
- Accepted `main` SHA: `b6cfc1fe7b690f09da9788717c140b8106f3c801`
- Merged release PR: [#68 — Integrate Product B safeguards and staff access fixes](https://github.com/IvayloNanev/Pulse-Studio/pull/68)
- Production: <https://pulse-studio-nyc.vercel.app>
- Production deployment state at closeout: Ready and Current at the accepted SHA
- Supabase: Pulse Studio, project `nsreydnhggxcwdjnekpb`, `ACTIVE_HEALTHY`
- Product B migration identifiers: `20260823143000_add_product_b_attendance_commands.sql` (Stage 2) and `20260825200000_add_product_b_session_safeguards.sql` (Stage 3)

## 3. What is complete

- Product B Stage 1 operational staff views and controls.
- Stage 2 attendance recording, atomic bulk recording, and immutable correction history.
- Stage 3 owner/admin cancellation safeguards, including the attendance-conflict guard and repeat protection.
- Authorization contracts and the shared Staff architecture.
- Production database-contract review and owner/admin read-only workflow.
- ESLint, webpack production build, and Playwright regression suite: 195/195 passing.
- Product A, Product C, Product D, and shared Staff regression review.
- Initial Product B mobile review at 390px.
- No P0, P1, P2, or P3 product defect reproduced.

## 4. What is not complete

- Live multi-role authenticated authorization evidence.
- Fixture A attendance and correction mutation evidence.
- Fixture A attendance-conflict cancellation evidence.
- Fixture B successful cancellation and repeat-protection evidence.
- Populated audit-history wrapping at 390px.
- Final release sign-off.

## 5. Synthetic acceptance inventory

Only these production records are approved for any future acceptance mutation:

| Type | Approved records |
| --- | --- |
| Staff | `TEST-EOD-OWNER`, `TEST-EOD-ASSIGNED`, `TEST-EOD-UNRELATED` |
| Fixture A | `TEST-EOD-PB-ATTENDANCE` |
| Fixture A reservations | `TEST-EOD-RES-A1`, `TEST-EOD-RES-A2`, `TEST-EOD-RES-AW` |
| Fixture B | `TEST-EOD-PB-CANCEL` |
| Fixture B reservations | `TEST-EOD-RES-B1`, `TEST-EOD-RES-BW` |
| Supporting data | Five explicit synthetic `TEST-EOD-*` members and their memberships/reservations |

No other production record is approved for acceptance mutation.

## 6. Current production state

The provisioned acceptance fixtures have zero formal acceptance effects:

- Attendance: 0
- Corrections: 0
- Cancellation actions: 0
- Notifications: 0
- Payments: 0
- Refunds: 0

No real member, real communication, or real financial record was affected.

## 7. Last attempted continuation

The multi-agent execution was abandoned to simplify coordination. The subsequent single-agent attempt correctly stopped at authentication: the available tooling could not establish secure, isolated sessions for the synthetic Staff identities without exposing or persisting authentication material. The STOP marker was preserved. No protected-route test, acceptance mutation, production fix, migration, deployment, or code change occurred.

This is an authentication/tooling evidence dependency, not a Product B defect.

## 8. Exact continuation decision

### Path A — Technical completion with acceptance waiver

Use Path A only if the program or team accepts the deployed release, database-contract evidence, regression suite, and read-only production review without the live synthetic mutation matrix.

Required actions:

- Document the waiver and its approver.
- Issue Product B technical release sign-off.
- Do not claim that the live mutation matrix was executed.

### Path B — Complete formal live acceptance

Use Path B only if the next operator has a compliant, normal supported application-authentication method for separately signing in as:

- `TEST-EOD-OWNER`
- `TEST-EOD-ASSIGNED`
- `TEST-EOD-UNRELATED`

The method must avoid direct Auth-table changes, credential exposure, and unapproved communications, and it must keep browser sessions isolated.

Once authentication is available, execute in order:

1. Unauthorized and invalid-operation tests first.
2. Fixture A individual attendance.
3. Fixture A atomic bulk attendance.
4. Unrelated-instructor correction denial.
5. Fixture A successful correction.
6. Fixture A attendance-conflict cancellation rejection.
7. Fixture B blank-reason rejection.
8. Fixture B successful owner cancellation.
9. Fixture B repeat-cancellation rejection.
10. Populated 390px audit-history review.
11. Final integrity and release report.

## 9. Non-negotiable continuation rules

- Never use real members or operational sessions.
- Never reuse one identity’s cookies for another.
- Never run successful mutations before negative tests.
- Never touch records outside the explicit `TEST-EOD-*` scope.
- Never reapply migrations or restart Product B Stages 1–3.
- Never reopen superseded PRs #63 or #66.
- Never begin Stage 4 as part of this closeout.
- Stop immediately if an unauthorized action succeeds.

## 10. Definition of done

Formal acceptance is complete only when the report verifies owner/admin authorization; assigned-instructor authorization; unrelated-instructor denial; waitlist exclusion; duplicate and cross-session bulk atomicity; actor attribution; correction history; attendance-conflict cancellation; successful cancellation; repeat protection; simulated notification behavior; zero real payment/refund effect; populated 390px audit history; unchanged GitHub/Vercel release identity; and zero P0–P3 findings.

Formal success language:

`PRODUCT B PRODUCTION ACCEPTANCE PASS`

`PRODUCT B READY FOR RELEASE SIGN-OFF`

## 11. Evidence index

Sanitized evidence available to the release coordinator includes:

- Product B production acceptance closeout and remaining-evidence package.
- EOD acceptance setup addendum and preserved STOP report.
- Stage 2 and Stage 3 database-contract verification records.
- 195/195 Playwright regression result, ESLint, and webpack production-build records.
- Initial 390px Product B mobile-review screenshots.

These materials are intentionally not linked to private temporary paths, browser state, credentials, or authentication artifacts.
